{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:16:59Z","timestamp":1788279419678,"version":"build-2803163510"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymeth.2026.07.013","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:10:08Z","timestamp":1785708608000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synergistic strategies combining nanomaterial-based oxygen modulation and immunotherapy for hepatocellular carcinoma"],"prefix":"10.1016","volume":"255","author":[{"given":"Chunzhong","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6277-5810","authenticated-orcid":false,"given":"Junsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2026.07.013_b0005","article-title":"A novel GSH depletor for simultaneous ferroptosis and cuproptosis Activation in hepatocellular carcinoma","volume":"117488","author":"Yang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1689103","article-title":"Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0015","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/ijms27042016","article-title":"Ultrasound-responsive calcium copper phosphate nanomaterials induce tumor cell death via the synergistic release of copper and calcium","volume":"27","author":"Qin","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymeth.2026.07.013_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119513","article-title":"Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer","volume":"585","author":"Nie","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ymeth.2026.07.013_b0025","doi-asserted-by":"crossref","first-page":"0247","DOI":"10.34133\/cbsystems.0247","article-title":"Hollow mesoporous carbon nanospheres derived from metal\u2013organic frameworks for efficient sono-immunotherapy against pancreatic cancer","volume":"6","author":"Chen","year":"2025","journal-title":"Cyborg Bionic Syst."},{"key":"10.1016\/j.ymeth.2026.07.013_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156094","article-title":"A multi-omic analysis reveals that Gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1","volume":"135","author":"Zheng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ymeth.2026.07.013_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1581398","article-title":"PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1","volume":"16","author":"Peng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0040","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001678","article-title":"Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma","author":"Ding","year":"2026","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13886","article-title":"CHB patients with rtA181T\u2010mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes","volume":"30","author":"Ning","year":"2023","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2317801121","article-title":"An animal model recapitulates human hepatic diseases associated with GATA6 mutations","volume":"122","author":"Shi","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0055","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0065","article-title":"Dual-doped metalloporphyrin MOFs-based nanoagent increases low-dose radiotherapy efficacy by apoptosis-ferroptosis for hepatocellular carcinoma","volume":"501","author":"Wang","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"Suppl","key":"10.1016\/j.ymeth.2026.07.013_b0070","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0075","doi-asserted-by":"crossref","unstructured":"G.A. Roldan, J. Blomker, E.S. Aby, Hepatocellular Carcinoma from a Hepatologist's Perspective, Seminars in Interventional Radiology, Thieme Medical Publishers, Inc., 2023, pp. 524-535.","DOI":"10.1055\/s-0043-1777846"},{"issue":"10126","key":"10.1016\/j.ymeth.2026.07.013_b0080","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ymeth.2026.07.013_b0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13046-019-1396-4","article-title":"From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma","volume":"38","author":"Fu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.ymeth.2026.07.013_b0095","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.3390\/jcm12237469","article-title":"The complexity of the tumor microenvironment in hepatocellular carcinoma and emerging therapeutic developments","volume":"12","author":"Argentiero","year":"2023","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.ymeth.2026.07.013_b0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","article-title":"Biomarkers for immunotherapy of hepatocellular carcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ymeth.2026.07.013_b0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12967-020-02667-4","article-title":"Hypoxia and the phenomenon of immune exclusion","volume":"19","author":"Pietrobon","year":"2021","journal-title":"J. Transl. Med."},{"issue":"13","key":"10.1016\/j.ymeth.2026.07.013_b0115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/1535370220934038","article-title":"Hypoxic tumor microenvironment: Implications for cancer therapy","volume":"245","author":"Roy","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ymeth.2026.07.013_b0120","article-title":"Role of hypoxia in the tumor microenvironment and targeted therapy","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ymeth.2026.07.013_b0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159473","article-title":"Cross-talk between HIF and PD-1\/PD-L1 pathways in carcinogenesis and therapy","volume":"132","author":"Shurin","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymeth.2026.07.013_b0130","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211036304","article-title":"Hypoxia and the tumor microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ymeth.2026.07.013_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1089446","article-title":"Hypoxia-responsive nanomaterials for tumor imaging and therapy","volume":"12","author":"Xia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1007960","article-title":"Biomimetic nanomaterial-facilitated oxygen generation strategies for enhancing tumour treatment outcomes","volume":"10","author":"Yang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.ymeth.2026.07.013_b0145","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/acs.molpharmaceut.3c00116","article-title":"Recent advances in perfluorocarbon-based delivery systems for cancer theranostics","volume":"20","author":"Yang","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymeth.2026.07.013_b0150","article-title":"Nanotechnological strategies to increase the oxygen content of the tumor","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2021.02.030","article-title":"Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: where do we stand?","volume":"125","author":"Yuan","year":"2021","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12672-025-01897-6","article-title":"Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0165","article-title":"Breaking hypoxic barrier: Oxygen-supplied nanomaterials for enhanced T cell-mediated tumor immunotherapy","volume":"100400","author":"Xiang","year":"2025","journal-title":"International Journal of Pharmaceutics: X"},{"key":"10.1016\/j.ymeth.2026.07.013_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611058","article-title":"Hypoxic characteristic in the immunosuppressive microenvironment of hepatocellular carcinoma","volume":"12","author":"Mo","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ymeth.2026.07.013_b0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.ymeth.2026.07.013_b0180","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, metabolic reprogramming, and drug resistance in liver cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"issue":"28","key":"10.1016\/j.ymeth.2026.07.013_b0185","doi-asserted-by":"crossref","first-page":"46691","DOI":"10.18632\/oncotarget.17358","article-title":"Hypoxia inducible factors in hepatocellular carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10555-022-10071-1","article-title":"Hypoxia signaling in hepatocellular carcinoma: challenges and therapeutic opportunities","volume":"42","author":"Sin","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","article-title":"Targeting hypoxia-inducible factors: therapeutic opportunities and challenges","volume":"23","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0200","first-page":"167","article-title":"Tumour hypoxia in driving genomic instability and tumour evolution","volume":"25","author":"Suvac","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.ymeth.2026.07.013_b0210","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3390\/cancers15102738","article-title":"Targeting hypoxia-inducible factor-1\u03b1 for the management of hepatocellular carcinoma","volume":"15","author":"Huynh","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108495","article-title":"Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1\u03b1\/METTL16\/lnc-CSMD1-7\/RBFOX2 axis","volume":"26","author":"Wang","year":"2023","journal-title":"Iscience"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0220","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-024-01963-5","article-title":"The p-MYH9\/USP22\/HIF-1\u03b1 axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma","volume":"9","author":"Shan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.ymeth.2026.07.013_b0225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/bmm-2021-1051","article-title":"Prognostic value of PD-L1 expression combined with hypoxia-associated immunosuppression in hepatocellular carcinoma","volume":"16","author":"Qian","year":"2022","journal-title":"Biomark. Med."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0235","first-page":"2595","article-title":"Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape","volume":"19","author":"Wen","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ymeth.2026.07.013_b0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2021.08.019","article-title":"Multifunctional biomaterials that modulate oxygen levels in the tumor microenvironment","volume":"521","author":"Hu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymeth.2026.07.013_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.649158","article-title":"Nanomaterials for tumor hypoxia relief to improve the efficacy of ROS-generated cancer therapy","volume":"9","author":"Ruan","year":"2021","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.ymeth.2026.07.013_b0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00424-020-02482-2","article-title":"Perfluorocarbon-based oxygen carriers: from physics to physiology","volume":"473","author":"J\u00e4gers","year":"2021","journal-title":"Pfl\u00fcgers Archiv-European Journal of Physiology"},{"issue":"11","key":"10.1016\/j.ymeth.2026.07.013_b0255","doi-asserted-by":"crossref","first-page":"17248","DOI":"10.1021\/acsanm.2c04241","article-title":"Nanocatalase-based oxygen-generating nanocarriers for active oxygen delivery to relieve hypoxia in pancreatic cancer","volume":"5","author":"Han","year":"2022","journal-title":"ACS Appl. Nano Mater."},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0260","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin\u2013MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0265","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/adfm.201404511","article-title":"Design of hybrid MnO2\u2010polymer\u2010lipid nanoparticles with tunable oxygen generation rates and tumor accumulation for cancer treatment","volume":"25","author":"Gordijo","year":"2015","journal-title":"Adv. Funct. Mater."},{"issue":"14","key":"10.1016\/j.ymeth.2026.07.013_b0270","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1039\/D2TB02751H","article-title":"Oxygen-generating biocatalytic nanomaterials for tumor hypoxia relief in cancer radiotherapy","volume":"11","author":"Zu","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ymeth.2026.07.013_b0280","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11523-020-00787-x","article-title":"The Evolving Landscape of Checkpoint Inhibitor Combination Therapy in the Treatment of Advanced Hepatocellular Carcinoma: L. Liu et al","volume":"16","author":"Liu","year":"2021","journal-title":"Target. Oncol."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-021-00350-4","article-title":"Recent advances in systemic therapy for hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomarker Res."},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0290","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/jfb15120357","article-title":"Regulation of oxygen in the tumor microenvironment synergizes with immunotherapy to suppress tumor progression","volume":"15","author":"Wang","year":"2024","journal-title":"Journal of Functional Biomaterials"},{"key":"10.1016\/j.ymeth.2026.07.013_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2024.01.010","article-title":"Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy","volume":"176","author":"Liu","year":"2024","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0300","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0305","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12951-024-03005-2","article-title":"Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy","volume":"22","author":"Feng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1471563","article-title":"Hypoxia-induced PD-L1 expression and modulation of muscle stem cell allograft rejection","volume":"15","author":"Raiten","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0315","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2021.06.001","article-title":"A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief","volume":"335","author":"Jiang","year":"2021","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.08.018","article-title":"Synergetic treatment of oxygen microcapsules and lenvatinib for enhanced therapy of HCC by alleviating hypoxia condition and activating anti-tumor immunity","volume":"34","author":"Sheng","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ymeth.2026.07.013_b0325","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174675","article-title":"Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia\u2013induced immunosuppression","volume":"10","author":"Halpin-Veszeleiova","year":"2025","journal-title":"JCI Insight"},{"issue":"18","key":"10.1016\/j.ymeth.2026.07.013_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207608","article-title":"Metabolic intervention liposome boosted lung cancer radio\u2010immunotherapy via hypoxia amelioration and PD\u2010L1 restraint","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0335","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12951-021-01034-9","article-title":"Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment","volume":"19","author":"Wang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.ymeth.2026.07.013_b0340","doi-asserted-by":"crossref","first-page":"883","DOI":"10.18632\/oncotarget.26608","article-title":"Oxygen in the tumor microenvironment: effects on dendritic cell function","volume":"10","author":"Paardekooper","year":"2019","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ymeth.2026.07.013_b0345","doi-asserted-by":"crossref","DOI":"10.1360\/nso\/20220053","article-title":"Dendritic cell maturation in the tumor microenvironment","volume":"2","author":"Miao","year":"2023","journal-title":"Natl. Sci. Open"},{"key":"10.1016\/j.ymeth.2026.07.013_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1278397","article-title":"Biomaterial-assisted local oxygenation safeguards the prostimulatory phenotype and functions of human dendritic cells in hypoxia","volume":"14","author":"Bhatt","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ymeth.2026.07.013_b0355","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3390\/app11083626","article-title":"Photodynamic therapy\u2014an up-to-date review","volume":"11","author":"Niculescu","year":"2021","journal-title":"Appl. Sci."},{"issue":"39","key":"10.1016\/j.ymeth.2026.07.013_b0360","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404146","article-title":"Piezoelectric Bilayer Nickel\u2010Iron Layered double Hydroxide Nanosheets with Tumor Microenvironment Responsiveness for Intensive Piezocatalytic Therapy","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1039\/D1BM00317H","article-title":"Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy","volume":"10","author":"Qin","year":"2022","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0370","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymeth.2026.07.013_b0375","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor cell-targeting and tumor microenvironment\u2013responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer","author":"Wang","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-020-01297-0","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0385","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12645-020-00072-6","article-title":"Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy","volume":"11","author":"Zhu","year":"2020","journal-title":"Cancer Nanotechnol."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0390","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12951-022-01476-9","article-title":"Nanoparticles mediated tumor microenvironment modulation: current advances and applications","volume":"20","author":"Raju","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0395","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2020.05.029","article-title":"Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia","volume":"324","author":"Dai Phung","year":"2020","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ymeth.2026.07.013_b0400","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s44222-022-00004-6","article-title":"Biomaterials tools to modulate the tumour microenvironment in immunotherapy","volume":"1","author":"Chao","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"issue":"7","key":"10.1016\/j.ymeth.2026.07.013_b0405","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41401-020-0424-4","article-title":"Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment","volume":"41","author":"Sun","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.ymeth.2026.07.013_b0410","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ymeth.2026.07.013_b0415","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0420","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/1061186X.2021.1999961","article-title":"Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy","volume":"30","author":"Deng","year":"2022","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0425","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12645-023-00173-y","article-title":"Boosting immunogenic cell death via hollow MnO2-based multiple stimuli-responsive drug delivery systems for improved cancer immunotherapy","volume":"14","author":"Wu","year":"2023","journal-title":"Cancer Nanotechnol."},{"issue":"40","key":"10.1016\/j.ymeth.2026.07.013_b0430","doi-asserted-by":"crossref","first-page":"44407","DOI":"10.1021\/acsami.0c08473","article-title":"Nanoparticle delivery of MnO2 and antiangiogenic therapy to overcome hypoxia-driven tumor escape and suppress hepatocellular carcinoma","volume":"12","author":"Chang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0435","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1039\/D5TB01925G","article-title":"Intelligent catalase-coated MnO 2 nanoparticles with programmed oxygen supply and glutathione depletion for enhanced photodynamic therapy","volume":"14","author":"Jia","year":"2026","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0445","first-page":"902","volume":"8","author":"Yang","year":"2017","journal-title":"Z.j.n.c. Liu, Hollow MnO2 as a Tumor-Microenvironment-Responsive Biodegradable Nano-Platform for Combination Therapy Favoring Antitumor Immune Responses"},{"key":"10.1016\/j.ymeth.2026.07.013_b0450","doi-asserted-by":"crossref","unstructured":"B. Li, X. Ye, Y. Fu, L. Feng, J. Xu, X. Niu, H. Ye, Z.J.P.R. You, Hollow MnO2-Based Nanoprobes for Enhanced Photothermal\/Photodynamic\/Chemodynamic Co-Therapy of Hepatocellular Carcinoma: Li et al, 40(5) (2023) 1271-1282.","DOI":"10.1007\/s11095-023-03501-4"},{"key":"10.1016\/j.ymeth.2026.07.013_b0455","first-page":"968","volume":"628","author":"Hou","year":"2022","journal-title":"Suo, I. Science, Hydrazide-Manganese Coordinated Multifunctional Nanoplatform for Potentiating Immunotherapy in Hepatocellular Carcinoma"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0460","first-page":"92","volume":"17","author":"Wang","year":"2022","journal-title":"NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced chemo\/PDT\/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinoma"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0465","first-page":"53","volume":"14","author":"Thomas","year":"2023","journal-title":"Lipo-MGN Nanoparticle Hypoxia Attenuation-Mediated Single-Dose Radiotherapy-and pH\/ROS-Responsive T1 Contrast Magnetic Resonance Imaging in Hepatocellular Carcinoma"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0470","first-page":"12748","volume":"12","author":"Malone","year":"2022","journal-title":"Achilefu, Activation of Nano-Photosensitizers by Y-90 Microspheres to Enhance Oxidative Stress and Cell Death in Hepatocellular Carcinoma"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0475","first-page":"10","volume":"20","author":"Guo","year":"2021","journal-title":"Two Nanoformulations Induce Reactive Oxygen Species and Immunogenetic Cell Death for Synergistic Chemo-Immunotherapy Eradicating Colorectal Cancer and Hepatocellular Carcinoma"},{"key":"10.1016\/j.ymeth.2026.07.013_b0480","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2147\/IJN.S353330","article-title":"Self-assembly catalase nanocomplex conveyed by bacterial vesicles for oxygenated photodynamic therapy and tumor immunotherapy","author":"Zhang","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0485","doi-asserted-by":"crossref","first-page":"11749","DOI":"10.1021\/acsnano.3c02592","article-title":"A near-infrared-II fluorescent nanocatalyst for enhanced CAR T cell therapy against solid tumor by immune reprogramming","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.ymeth.2026.07.013_b0490","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1021\/acs.nanolett.8b02720","article-title":"Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer","volume":"18","author":"Song","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymeth.2026.07.013_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102527","article-title":"Folic acid-modified phthalocyanine-nanozyme loaded liposomes for targeted photodynamic therapy","volume":"36","author":"Nwahara","year":"2021","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.ymeth.2026.07.013_b0500","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.coph.2020.08.010","article-title":"Alleviating tumor hypoxia with perfluorocarbon-based oxygen carriers","volume":"53","author":"Krafft","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"issue":"10","key":"10.1016\/j.ymeth.2026.07.013_b0505","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1021\/acsnano.0c05617","article-title":"Perfluorocarbon@ Porphyrin nanoparticles for tumor hypoxia relief to enhance photodynamic therapy against liver metastasis of colon cancer","volume":"14","author":"Liang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymeth.2026.07.013_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102407","article-title":"Therapeutic oxygen delivery by perfluorocarbon-based colloids","volume":"294","author":"Krafft","year":"2021","journal-title":"Adv. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2026.07.013_b0515","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.apsb.2021.07.025","article-title":"Perfluorooctyl bromide nanoemulsions holding MnO2 nanoparticles with dual-modality imaging and glutathione depletion enhanced HIFU-eliciting tumor immunogenic cell death","volume":"12","author":"Kuai","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymeth.2026.07.013_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114344","article-title":"Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment","volume":"186","author":"Choi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40820-019-0347-0","article-title":"Recent advances in tumor microenvironment hydrogen peroxide-responsive materials for cancer photodynamic therapy","volume":"12","author":"Yang","year":"2020","journal-title":"Nano-Micro Letters"},{"issue":"34","key":"10.1016\/j.ymeth.2026.07.013_b0530","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1039\/D1TB00554E","article-title":"Phototherapy and multimodal imaging of cancers based on perfluorocarbon nanomaterials","volume":"9","author":"Han","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0535","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0540","article-title":"Oxygen-based nanocarriers to modulate tumor hypoxia for ameliorated anti-tumor therapy: fabrications, properties, and future directions","volume":"8","author":"Li","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0545","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/acsabm.0c01328","article-title":"Nanoenabled tumor oxygenation strategies for overcoming Hypoxia-Associated immunosuppression","volume":"4","author":"Zhang","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ymeth.2026.07.013_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122481","article-title":"Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma","volume":"306","author":"Pan","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymeth.2026.07.013_b0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2023.01.051","article-title":"The application of nanoparticles in immunotherapy for hepatocellular carcinoma","volume":"355","author":"Hu","year":"2023","journal-title":"J. Control. Release"},{"issue":"16","key":"10.1016\/j.ymeth.2026.07.013_b0560","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.3390\/nano12162832","article-title":"Nanoparticle-based therapeutics to overcome obstacles in the tumor microenvironment of hepatocellular carcinoma","volume":"12","author":"Lu","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ymeth.2026.07.013_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100159","article-title":"Nanoparticle drug delivery systems in hepatocellular carcinoma: a focus on targeting strategies and therapeutic applications","volume":"12","author":"Metkar","year":"2023","journal-title":"OpenNano"},{"issue":"9","key":"10.1016\/j.ymeth.2026.07.013_b0570","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.3390\/ijms24098308","article-title":"Synergistic nanomedicine: photodynamic, photothermal and photoimmune therapy in hepatocellular carcinoma: fulfilling the myth of prometheus?","volume":"24","author":"Ailioaie","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102508","article-title":"Current advances in nanoparticle-based approaches for the hepatocellular carcinoma treatment","volume":"49","author":"Paranthaman","year":"2025","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0580","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1438819","article-title":"Application of nanotechnology in the treatment of hepatocellular carcinoma","volume":"15","author":"Cai","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0585","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101512","article-title":"Nanoparticle-based medicines in clinical cancer therapy","volume":"45","author":"Wang","year":"2022","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0595","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12645-024-00302-1","article-title":"Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts","volume":"16","author":"Zhang","year":"2025","journal-title":"Cancer Nanotechnol."},{"issue":"8","key":"10.1016\/j.ymeth.2026.07.013_b0600","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s43018-025-01025-x","article-title":"Nanotechnology for immuno-oncology","volume":"6","author":"Grippin","year":"2025","journal-title":"Nature Cancer"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0605","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40364-024-00625-6","article-title":"Cancer immunotherapy and its facilitation by nanomedicine","volume":"12","author":"Sui","year":"2024","journal-title":"Biomarker Res."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0610","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40164-025-00658-z","article-title":"Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0615","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11051-023-05690-w","article-title":"Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review","volume":"25","author":"Abbasi","year":"2023","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ymeth.2026.07.013_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114828","article-title":"Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function","volume":"197","author":"Uzhytchak","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0625","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/genes14030590","article-title":"Nanoplastics toxicity specific to liver in inducing metabolic dysfunction\u2014a comprehensive review","volume":"14","author":"Haldar","year":"2023","journal-title":"Genes"},{"issue":"14","key":"10.1016\/j.ymeth.2026.07.013_b0630","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.3390\/ijms241411869","article-title":"Liver cell type-specific targeting by nanoformulations for therapeutic applications","volume":"24","author":"Kaps","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ymeth.2026.07.013_b0635","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1039\/D3NH00145H","article-title":"Selective organ targeting nanoparticles: from design to clinical translation","volume":"8","author":"Li","year":"2023","journal-title":"Nanoscale Horiz."},{"issue":"8","key":"10.1016\/j.ymeth.2026.07.013_b0640","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","article-title":"Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications","volume":"31","author":"Safri","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0645","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","article-title":"Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside","volume":"13","author":"Yin","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.ymeth.2026.07.013_b0650","article-title":"Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0655","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43046-023-00186-z","article-title":"Mechanisms of HIF-driven immunosuppression in tumour microenvironment","volume":"35","author":"Bandopadhyay","year":"2023","journal-title":"J. Egypt. Natl. Canc. Inst."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0660","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0665","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41416-024-02684-w","article-title":"The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications","volume":"131","author":"Chen","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0670","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s43088-023-00458-6","article-title":"Nanotoxicological profiles of clinically approved nanoplatforms","volume":"12","author":"Nkanga","year":"2023","journal-title":"Beni-Suef University Journal of Basic and Applied Sciences"},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0675","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae055","article-title":"Application of nanomedicines in tumor immunotherapy","volume":"16","author":"Gao","year":"2024","journal-title":"J. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0680","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/pharmaceutics14010041","article-title":"Nanomedicine in hepatocellular carcinoma: a new frontier in targeted cancer treatment","volume":"14","author":"Bakrania","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ymeth.2026.07.013_b0685","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.3390\/ma15113893","article-title":"Al Hajjar, Nanotechnology in the diagnostic and therapy of hepatocellular carcinoma","volume":"15","author":"Graur","year":"2022","journal-title":"Materials"},{"issue":"12","key":"10.1016\/j.ymeth.2026.07.013_b0690","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41565-024-01753-8","article-title":"Designing nanotheranostics with machine learning","volume":"19","author":"Rao","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0695","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.70027","article-title":"Machine learning and artificial intelligence in nanomedicine","volume":"17","author":"Chou","year":"2025","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.ymeth.2026.07.013_b0700","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the biodistribution and clearance of nanomedicines","volume":"2","author":"Cabral","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"1","key":"10.1016\/j.ymeth.2026.07.013_b0705","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12951-020-00629-y","article-title":"Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges","volume":"18","author":"Jin","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.ymeth.2026.07.013_b0710","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:24:48Z","timestamp":1788276288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":141,"alternative-id":["S1046202326001696"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.07.013","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic strategies combining nanomaterial-based oxygen modulation and immunotherapy for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}